tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
Holding OVID?
Track your performance easily

Ovid Therapeutics (OVID) Financial Statements

1,291 Followers

Ovid Therapeutics Financial Overview

Ovid Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.459; its P/E ratio is -2.31; Ovid Therapeutics is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 173.00K$ 169.00K$ 148.00K$ 141.56K$ 108.97K
Gross Profit$ 173.00K$ 169.00K$ 148.00K$ 141.56K$ 108.97K
EBIT$ -14.01M$ -20.52M$ -11.69M$ -18.19M$ -12.03M
EBITDA$ -13.56M$ -20.52M$ -11.29M$ -17.79M$ -11.63M
Net Income Common Stockholders$ -14.01M$ 8.37M$ -11.69M$ -15.32M$ -11.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 62.71M$ 76.97M$ 90.26M$ 105.83M$ 87.07M
Total Assets$ 102.65M$ 118.09M$ 131.61M$ 144.03M$ 125.03M
Total Debt$ 15.07M$ 15.39M$ 15.70M$ 16.00M$ 16.30M
Net Debt$ -47.64M$ -61.58M$ -74.56M$ -89.83M$ -70.77M
Total Liabilities$ 26.36M$ 29.19M$ 53.33M$ 56.23M$ 23.74M
Stockholders Equity$ 76.29M$ 88.90M$ 78.28M$ 87.80M$ 101.29M
Cash Flow-
Free Cash Flow$ -15.00M$ -14.23M$ -16.72M$ -11.91M$ -10.06M
Operating Cash Flow$ -15.00M$ -14.20M$ -16.70M$ -11.91M$ -10.05M
Investing Cash Flow$ 292.00K$ 12.82M$ 20.19M$ -48.52M$ -4.36M
Financing Cash Flow$ 38.00K$ 356.00K$ 228.00K$ 30.03M$ 223.72K
Currency in USD

Ovid Therapeutics Earnings and Revenue History

Ovid Therapeutics Debt to Assets

Ovid Therapeutics Cash Flow

Ovid Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis